Liver Resection for Primary Hepatic Angiosarcoma: Bicentric Analysis of a Challenging Entity.
hepatic angiosarcoma
hepatic resection
overall survival
tumor rupture
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
25 May 2022
25 May 2022
Historique:
received:
23
04
2022
revised:
16
05
2022
accepted:
22
05
2022
entrez:
10
6
2022
pubmed:
11
6
2022
medline:
11
6
2022
Statut:
epublish
Résumé
Primary hepatic angiosarcoma (PHA) is a rare malignant tumor of the liver, and data on patient outcome after surgical treatment are scarce. The aim of this study was to evaluate postoperative morbidity and overall survival (OS) of patients who underwent hepatectomy for PHA. This is a bicentric retrospective analysis of all consecutive patients who underwent liver resection in curative intent for PHA between 2012 and 2019 at the University Hospital of Muenster and the University Hospital of Bern. Nine patients (five female, four male) were included from both centers. Median age was 72 years (44-82). Most lesions (77.8%) were larger than 5 cm, and mean size of the biggest lesion was 9.4 ± 4.5 cm. Major hepatectomy was performed in four (44.4%), and radical resection (R0) was achieved in six (66.7%) patients. Postoperative complication rate was 88.8%, including 44.4% higher than 3a in the Clavien-Dindo classification. OS survival rates at 1, 2, and 3 years were 44.4%, 22.2%, and 12.5%, respectively, and median OS was 5 months. OS was significantly better after radical resection (R0: 15 months vs. R1: 0 months,
Identifiants
pubmed: 35683376
pii: jcm11112990
doi: 10.3390/jcm11112990
pmc: PMC9181818
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Clin Radiol. 2009 Aug;64(8):779-85
pubmed: 19589416
World J Gastroenterol. 2006 Feb 7;12(5):804-8
pubmed: 16521200
Arch Surg. 2009 Apr;144(4):339-44; discussion 344
pubmed: 19380647
J Surg Oncol. 2016 Feb;113(2):127-9
pubmed: 26663366
BMC Gastroenterol. 2021 Apr 7;21(1):156
pubmed: 33827427
Surg Endosc. 2010 May;24(5):1170-6
pubmed: 19915908
Sci Rep. 2017 Apr 21;7(1):1012
pubmed: 28432295
Dig Surg. 1998;15(6):674-8
pubmed: 9845635
World J Gastroenterol. 2015 May 21;21(19):6088-96
pubmed: 26019478
Am J Cancer Res. 2019 Nov 01;9(11):2303-2313
pubmed: 31815036
Semin Liver Dis. 2008 Aug;28(3):302-14
pubmed: 18814083
Cancer Med. 2021 Dec;10(24):8883-8890
pubmed: 34850580
BMC Surg. 2019 Jan 10;19(1):5
pubmed: 30630447
J Gastroenterol Hepatol. 2014 May;29(5):906-11
pubmed: 24372769
BMJ Case Rep. 2013 May 22;2013:
pubmed: 23704445
Clin Liver Dis. 2001 Feb;5(1):219-57, viii
pubmed: 11218917
Clin Epidemiol. 2012;4:283-301
pubmed: 23152705
Environ Health Perspect. 1981 Oct;41:115-6
pubmed: 7199427
Cureus. 2018 Sep 11;10(9):e3283
pubmed: 30443453
Nat Rev Gastroenterol Hepatol. 2020 Dec;17(12):755-772
pubmed: 32681074
Ann Gastroenterol Surg. 2020 Dec 13;5(3):287-295
pubmed: 34095718
AJR Am J Roentgenol. 2018 Jan;210(1):175-182
pubmed: 29090997
Medicine (Baltimore). 2015 May;94(19):e816
pubmed: 25984668
Dig Dis Sci. 2003 Apr;48(4):677-82
pubmed: 12741455
Eur J Surg Oncol. 2015 Sep;41(9):1137-43
pubmed: 26008857
Intern Med. 2018 Mar 1;57(5):687-691
pubmed: 29151516
Med Sci Monit. 2010 Feb;16(2):CR61-6
pubmed: 20110916
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
Am J Forensic Med Pathol. 2000 Jun;21(2):134-7
pubmed: 10871127
Environ Health Perspect. 1981 Oct;41:107-13
pubmed: 7199426
Cancer Biol Med. 2016 Dec;13(4):426-442
pubmed: 28154774
Int J Surg Case Rep. 2016;28:165-168
pubmed: 27718433
BMC Gastroenterol. 2011 Dec 26;11:142
pubmed: 22200164